Research Group

Publications

Date Publication	Title	Journal
2006-05	A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition.
2009-10	An A13 repeat within the 3'-untranslated region of epidermal growth factor receptor (EGFR) is frequently mutated in microsatellite instability colon cancers and is associated with increased EGFR expression.
2009-09	An A13 repeat within the 3'-untranslated region of epidermal growth factor receptor (EGFR) is frequently mutated in microsatellite instability colon cancers and is associated with increased EGFR expression.
2010-01	Apoptotic sensitivity of colon cancer cells to histone deacetylase inhibitors is mediated by an Sp1/Sp3-activated transcriptional program involving immediate-early gene induction
2010-04	Aprataxin tumor levels predict response of colorectal cancer patients to irinotecan-based treatment
2012-01	Brush border Myosin Ia has tumor suppressor activity in the intestine
2013-04	Brush border myosin Ia inactivation in gastric but not endometrial tumors.
2012-04	Candidate driver genes in microsatellite-unstable colorectal cancer.
2008-08	EPH receptors in cancer
2006-09	EPHB4 and survival of colorectal cancer patients

Year	Title	Funding Agency
2005	Estudio de EPHB4 en cáncer colorectal	Fundación Invest. Médica Mutua Madrileña
2010	Grup d'Oncologia Molecular	AGAUR
2008	La GTPasa RhoA en cáncer colorectal	Fundación Invest. Médica Mutua Madrileña
2008	Los receptores EPH y el cáncer colorectal.	Ministerio de Ciencia e Innovación
2012	Maintenance of the epithelial brush border and colorectal cancer	ISCIII
2009	Marcadores de respuesta a Irinotecan en pacientes con cáncer colorrectal	Ministerio de Ciencia e Innovación
2012	MYO5B in colorectal cancer	Association for International Cancer Research
2005	Papel funcional de los receptores con actividad quinasa EPH y sus ligandos Efrina en el cáncer colorectal.	Fondo de Investigación Sanitaria
2005	Papel funcional de los receptores con actividad quinasa EPH y sus ligandos en el cáncer colorectal	Fondo de Investigación Sanitaria
2012	Validation of Aprataxin as a biomarker of response to Topoisomerase I inhibitors in cancer patients VALPRAXIN	Instituto de Salud Carlos III

Title	City	Date	Event Type
AACR 2006. Annual Meeting	Whasington (USA)	From Sat, 2006-04-01 To Wed, 2006-04-05	Congress
AACR 2007 Annual Meeting	Los Angeles, CA (USA)	From Sat, 2007-04-14 To Wed, 2007-04-18	Congress
ASEICA 2009 XII Congreso Nacional	Madrid	From Wed, 2009-05-06 To Fri, 2009-05-08	Congress
ASEICA Meeting 2007	Las Palmas de Gran canaria	From Thu, 2007-05-10 To Sat, 2007-05-12	Congress
ASHG 2008. 58th Annual Meeting	Philadelphia (USA)	From Tue, 2008-11-11 To Sat, 2008-11-15	Congress
Proceedings of the American Association for Cancer Research,	Washington (USA)	From Thu, 2010-04-01 To Thu, 2010-04-01	Congress